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Automated robust proton planning using dose-volume histogram based mimicking 
of the photon reference dose and reducing organ at risk dose optimization 
 
Running title: Automated robust proton planning  
 
Summary (<75 words) 
An automated approach to robust pencil beam scanning proton planning has been presented by first 
mimicking the dose-volume histograms of the photon dose and secondly reducing the dose to non-target 
tissues. This ‘mimicking and reducing’ algorithm was evaluated in head and neck cancer patients and 
successfully embedded into a framework to automatically select patients for proton therapy based on 
normal tissue complication probabilities. 
 
Abstract (<300 words) 
Patient selection for proton therapy is increasingly based on proton to photon plan comparisons. To 
improve efficient decision making, we developed a dose mimicking and reducing (DMR) algorithm to 
automatically generate a robust proton plan from a reference photon dose and target and organs at risk 
(OARs) delineations.  
The DMR algorithm was evaluated in 40 head and neck cancer patients. The first step of the DMR 
algorithm comprises DVH-based mimicking of the photon dose distribution in the clinical target volumes 
and OARs. Target robustness is included by mimicking the nominal photon dose in 21 perturbed 
scenarios. The second step of the optimization aims to reduce the OAR doses while retaining the robust 
target coverage as achieved in the first step. We evaluated each DMR plan against the ‘manually’ robustly 
optimized reference proton plan in terms of plan robustness (voxel-wise minimum dose). Furthermore, the 













(NTCP) models of xerostomia, dysphagia and tube feeding dependence. Consequently, ∆NTCPs were 
defined as the difference between the NTCPs of the photon and proton plans. 
The dose distributions of the DMR and reference proton plans were very similar in terms of target 
robustness and OAR dose values. Regardless of proton planning technique (i.e. DMR or reference proton 
plan), the same treatment modality was selected in 80% (32/40) of cases based on the ∑∆NTCPs. In 15% 
(6/40) of cases a conflicting decision was made based on relatively small dose differences to the OARs 
(<2.0 Gy). 
The DMR algorithm automatically optimized robust proton plans from a photon reference dose 
comparable to the dosimetrist-optimized proton plans in head and neck cancer patients. This algorithm has 
been successfully embedded into a framework to automatically select patients for proton therapy based on 
normal tissue complication probabilities. 
 
Introduction 
Head and neck cancer (HNC) patients are often treated with radiotherapy with or without systemic 
treatment and/or surgery. Modern radiotherapy includes intensity modulated techniques using either 
photons or protons. The current standard radiation technique is intensity modulated radiotherapy (IMRT) 
or volumetric modulated arc therapy (VMAT) aiming at highly conformal target coverage with sparing of 
non-target tissues. The physical properties of the proton beam (i.e., the Bragg peak) may even further 
improve dose conformity with less dose to organs at risk (OARs) [1,2]. In particular, the relatively recent 
introduction of pencil beam scanning (PBS) technology, together with robust multi-field optimization 
(MFO), has shown the greatest promise in reducing non-target dose, especially in complex target regions 
such as HNC [3]. Due in part to these benefits, there has been a steep increase in the availability of PBS 
world-wide, through both new facilities as well as existing facilities upgrading to PBS from older 














In the Netherlands, patients selection for proton therapy in HNC is performed using the ‘model-based 
approach’, a national framework which outlines the criteria in which a significant clinical benefit can be 
expected relative to photon treatments [4,5]. This approach uses normal tissue complication probability 
(NTCP) models to compare the expected radiation-induced side effects (such as grade 2 xerostomia, 
dysphagia and grade 3 tube feeding dependence) arising from both proton and photon therapy, based upon 
the dose distribution of the patient’s treatment plan and clinically relevant prognostic factors. If the 
difference between NTCP values (∆NTCP) of the two plans is above a pre-defined threshold, the patient is 
eligible for proton therapy. 
Cheng et al. developed a pipeline to automatically calculate the preferred treatment modality per patient 
based on dose, toxicity (i.e. NTCP models) and cost-effectiveness within minutes [6]. The time and 
resource intensive generation of photon and proton treatment plans for each patient were however not 
included in their analysis. This is a substantial departmental burden which would greatly benefit from 
automation. 
Several approaches to (semi-) automated treatment planning have been presented in literature [7-13]. 
Examples of automated planning tools include the use of knowledge-based planning using previously 
approved treatment plans of different patients [7,8] and multicriteria optimization methods [9–13]. 
Recently, McIntosh et al. created an automated plan by mimicking a predicted dose distribution directly 
derived from the planning image and a set of automatically selected previously treated similar patients 
[14]. They mimicked photon dose of HNC patients on a voxel-level and demonstrated similar plan quality 
as compared to dosimetrist-optimized plans. XXXX introduced a mimicking algorithm to automatically 
improve treatment plans by optimization under reference dose constraints [15]. This algorithm uses a 
reference dose distribution as a starting point and then optimizes further, either on a dose volume 
histogram (DVH) basis or on a voxel basis to improve a plan without deteriorating the reference dose 
distribution. All these publications however have only addressed non-robust plan automation for photons.  
In this study, we extended the work of XXXX [15] towards photon to robust proton dose mimicking and 













automatically generates a robust MFO proton plan given a reference photon dose distribution and target 
and OAR delineations, and was evaluated in 40 HNC patients. The first step of the optimization process 
consists of robust DVH-based mimicking of the target, accounting for range and setup uncertainties. Due 
to the characteristics of proton beams, there is room to further improve the dose to the non-target tissues. 
The second step of the optimization therefore aims to reduce the OAR dose as much as possible. The 
presented reducing OAR dose optimization aims to not deteriorate on target coverage as achieved during 
the first step, also accounting for plan robustness. The goal of this study was to determine whether this 
new DMR algorithm was able to generate a robustly optimized proton plan of equal or better ‘quality’ 
than the reference, dosimetrist-optimized proton plan. If so, the algorithm could be used within an 
automated workflow to determine the selection of HNC patients that would benefit from proton therapy 
the most. 
 
Material and methods 
Patients 
Forty HNC patients that were prospectively registered at our institute between September 2014 and June 
2016 and that were treated to the primary tumors and to the elective lymph nodal areas, at both sides of the 
neck, and that had weekly acquired repeat CT images available (as part of our quality assurance 
programme) were enrolled in this study. All patients were treated with curative intent using IMRT (n = 
14) or VMAT (n = 26) with or without concomitant chemotherapy or cetuximab. Tumors were staged with 
TNM classifications of T1-4, N0-3, and M0-1 and originated in the nasopharynx (n = 4), glottic larynx (n 
= 6), hypopharynx (n = 5), oropharynx (tonsil: n = 7; base of tongue: n = 6 posterior wall: n = 1), 
supraglottic larynx (n = 7), oral cavity (n = 2), and other regions (n = 2).  
All patients were treated with a simultaneous integrated boost technique comprising the following dose 
level prescriptions: 70 Gy (in 2 Gy per fraction, 5 fractions per week) to the primary clinical target volume 















Reference photon plan (Xref) 
All photon plans were optimized by dosimetrists in the clinical version of the RayStation treatment 
planning system (v4.5, RaySearch Laboratories AB, Stockholm, Sweden). Each plan was created to 
adequately cover the planning target volume (PTV) (V95≥98% for PTV1 and PTV2; relative volume 
receiving 95% of the prescribed dose) with maximum acceptable doses to the spinal cord and brain of 54 
and 60 Gy, respectively. The dose to both parotid glands and swallowing structures (including the superior 
pharyngeal constrictor muscle and supraglottic larynx, according to XXXX et al.[16]) were prioritized 
optimized as described previously [17]. The IMRT plans consisted of 7 equispaced beams (6 MV) with a 
maximum of 84 segments. The VMAT plans comprised a dual-arc (360˚) with a maximum constrained 
leaf motion of 0.25 cm/deg. The dose grid was 0.3 x 0.3 x 0.3 cm3 for all plans. The final photon dose was 
calculated using a collapsed cone dose engine. 
 
Reference proton plan (Pref) 
For each patient, a robustly optimized PBS proton plan was created by one dosimetrist using MFO as 
implemented in RayStation (v4.99.0). Four beams were used, including two anterior oblique beams 
(gantry and couch angles: beam 1 approx. 50˚ and 340˚; beam 2 approx. 310˚ and 20˚) and two beams 
from posterior oblique direction (gantry and couch angles: beam 3 approx. 150˚ and 0˚; beam 4 approx. 
200˚ and 0˚). To avoid any range uncertainties in the shoulder and neck region, only the anterior beams 
contributed to the caudal part of the target. Moreover, the beam directions were manually chosen such that 
dose to the parotids was avoided as much as possible. All beams used a 4.0 cm range shifter to allow for 
adequate coverage of superficial target volumes. The air gap between the range shifter and the patient was 
kept at minimum. 
The PBS plans were created using minimax robust optimization with a range uncertainty of 3.0 % and an 













nominal energy available ranged from 70 - 225 MeV. The minimum spot weight was 0.01 monitor units 
per spot. The spot and layer spacing was set to ‘automated scale 1.0’. The Pref plans were prioritized 
optimized using robust minimum dose objectives for the CTVs, a dose fall-off objective for the body 
contour, and dose fall-off objectives as well as maximum equivalent uniform dose objectives (with dose-
volume effect parameter a = 1) for the OARs. 
Pipeline model-based approach 
The model-based approach has previously been introduced to select the preferred treatment modality for 
the individual patient, based on NTCP models[4]. The selection is based on ∆NTCP values as derived 
from e.g. a photon and a proton dose distribution and evaluated against predefined thresholds. If the pre-
established ∆NTCP threshold is exceeded, the patient is referred for proton therapy, otherwise the patient 
receives photon radiotherapy. Figure 1 illustrates how ∆NTCP is derived using the DMR algorithm given 
a reference photon dose and corresponding decision criteria. The NTCP models as well as the thresholds 
for different grades of complication are shown in table 1. These NTCP models and thresholds have 
recently been established in the ‘Dutch National Indication Protocol for Proton Therapy’ [18]. 
Dose mimicking 
PBS proton treatment plans were automatically generated using an extended version of the original 
‘reducing OAR dose’ algorithm as described by [15]. Our extension comprised of photon to robust proton 
dose mimicking and was implemented in a research version of RayStation (v5.99.0). The DMR algorithm 
consists of the following components, as illustrated in Figure 1: 
1. The beam angles are selected.  
2. The ROIs that are to be considered in the optimization are selected. 
3. The reference dose is set to the dose distribution of the photon plan to be mimicked. 
4. A robust dose mimicking optimization is performed using 21 perturbed scenarios.  














In the present study, the algorithm was instantiated as follows: 
To avoid any bias from proton beam angle selection, the beam configuration (step 1) of the DMR plans 
was copied from the reference proton plans. In the ROI selection (step 2), the CTVs and OARs related to 
patient-rated xerostomia, grade II-IV dysphagia and tube feeding dependence, and the spinal cord were 
included (see Table 1). Then the reference dose is set to Xref (step 3). 
In the mimicking part (step 4), the DMR algorithm comprised DVH-based mimicking of Xref in the CTVs 
and OARs. This optimization aims to achieve a proton plan that has at least similar target coverage, also 
when uncertainty is considered, and at least similar OAR sparing as in the photon dose set in step 3. The 
DVH-based mimicking minimized the deviation between the DVHs of Xref and those of the proton plan 
being optimized. Plan robustness was only considered for the targets, and achieved by mimicking the 
nominal photon dose in each uncertainty scenario. Mathematically, the DVH-based mimicking utilizes the 
function ref, which parameterizes the DVH of ROI 	 in the photon reference dose distribution as a 
function of the fraction  ∈ 0,1] of the ROI volume, i.e., ref0.9 is D90 in the photon reference dose 
distribution. It also utilizes the function ; , , which is like ref, but in the dose distribution of 
the proton plan being optimized for the spot weights  under scenario . The objective function, which is 
to be minimized, is formulated as 
 max; ,  − ref, 0			

	∈
+ max; ,  − ref, 0			
 !
	∈"#∈$





where % is the set of considered OARs, & is the set of considered targets, ' is the set of considered 
scenarios, and  denotes the nominal (planning) scenario. The parameter  specifies where over- and 
underdosage should be penalized for targets. Per default, it was set to 0.5, but to include the dose gradient 
between low and high dose targets more accurately, it was set to 0.9 for targets where (D10 - D90) / D10 > 













fractional volume  lies within the grey area (as in figure 3, bounded by the reference photon DVH), the 
dose is penalized by the objective function (third part of abovementioned formula). 
In the ‘reducing OAR dose optimization’ step (step 5), the DMR algorithm aimed to reduce OAR doses as 
much as possible while retaining the plan quality achieved in step 4 in a DVH-based fashion. To this end, 
constraints were introduced preventing the DVHs of the plan to deteriorate compared to the proton 
mimicking plan of step 4. Under each uncertainty scenario, the DVH of each target was constrained not to 
deteriorate compared to the DVH of the mimicking plan in the same scenario. XXXX describes this fifth 
step of the DMR algorithm, without considering robustness [15]. Mathematically, the OAR dose reduction 
optimization problem uses the functions from the DVH-based mimicking objective as constraints, but 
substitutes the function ref;  for ref, where ref;  parameterizes the DVH of ROI 	 in the 
dose distribution under scenario	 of the proton plan achieved by the mimicking in step 4. The objective 
function, which is to be minimized, is formulated as 
 




and the constraints as 












The DMR optimization time (step 2 – 5) depended on the number of iterations, the number of dose grid 
voxels and target size and ranged from approximately 120 to 240 minutes in RayStation v5.991. The dose 
mimicking optimization (step 4) contained three optimizations rounds each with 50 iterations. The 
reducing OAR dose optimization (step 5) was performed with 50 iterations. 
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For each proton plan (i.e. DMR and Pref plan), plan robustness was assessed by evaluating the treatment 
plan under 14 rigidly perturbed and equally distributed setup error scenarios. The collection of scenarios is 
sampled from a cube and projected on a sphere with radius M. In total, 8 vertices (x=±M/√3, y=±M/√3, 
z=±M/√3) and 6 faces (±M, 0,0); (0, ±M, 0); (0, 0, ±M) were used to derive the scenarios. For all 
scenarios the image was scaled by ±3% to account for range uncertainty. From the resulting 28 scenarios, 
a voxel-wise minimum dose was constructed from which the V95% of the CTV was derived and 
compared between the DMR and Pref plan. In addition, plans were evaluated in terms of (∆)NTCP values 
(see table 1) and target conformity (CIV95%). The CIV95% was defined as the ratio between the absolute 
volume of the 95% isodose line and the V95% in the CTV.  
 
Results 
The DMR algorithm created clinically realistic robust treatment plans that were comparable to the 
reference proton plans in terms of target robustness and OAR dose. The distribution of a photon dose (i.e. 
Xref) and the voxel-wise minimum dose of the DMR and Pref of a representative case are shown in figure 
2. The target coverage of the nominal scenario was very similar in the photon and proton plans (see target 
DVHs in figure 3). The DVHs indicated the result of the ‘dose mimicking’ step as well as the ‘reducing’ 
step. The latter indicates a clear reduction of OAR dose whereas the targets remained constrained to the 
target DVH of the reference photon plan. 
In 80% (32/40) of the cases, the DMR algorithm selected the same patients for proton therapy as if Pref 
was used for patient selection. In 15% (6/40) of cases a conflicting decision was made based on relatively 
small (approx. <2.0 Gy) dose differences to the OARs. For these borderline cases, one plan (e.g. the DMR 
plan) would meet the decision criteria for proton therapy selection in terms of ∑∆NTCP thresholds, 
whereas the other plan (e.g. Pref plan) would not qualify for proton therapy (or vice versa). In 5% (2/40) 













plan was compromised resulting in too optimistic OAR doses (and NTCP values) and conflicting 
decisions compared to the reference proton plan.  
With the DMR plans 10% more patients of the studied cohort qualified for proton therapy as compared to 
the Pref plans. The difference between the ∑∆NTCP values derived from the DMR and the Pref plans was 
however small: on average (±1.96 SD) 2.2 (±12.3) % (figure 4a). The scatter plot (figure 4b) shows high 
agreement between the NTCP values of xerostomia, grade II-IV dysphagia, and tube feeding dependence 
as derived from the DMR and Pref plan.  
The difference of V95% of the voxel-wise minimum dose between the DMR and the Pref plan was <0.05 
in 35/40 and 37/40 of the cases for CTV1 and CTV2, respectively (figure 5a). The two outliers indicate 
the DMR plans that were optimized given an underdosed target DVH of the reference photon plans. The 
CIV95% of the voxel-wise minimum dose indicated that the DMR and Pref plan had, on average, similar 
target dose conformity for CTV1 (t-test using the 0.05 significance level: p = 0.16). On average (±1.96 
SD), the CIV95% of the voxel-wise minimum dose distribution of CTV2 was 0.22 (±0.41) (p < 0.001) lower 
for the Pref plan than for the DMR plan, indicating slightly more conformal target coverage of the voxel-
wise minimum dose of the Pref plans (figure 5b).  
Discussion 
The dose ‘mimicking and reducing’ algorithm turned a photon dose distribution into a robust MFO proton 
plan comparable to the dosimetrist-optimized proton plan for 40 HNC patients. We simulated the model-
based approach within this cohort (i.e. the calculation of ∑∆NTCP values from the proton and photon dose 
distribution) and found that the DMR algorithm selected 80% of cases for the same treatment technique as 
when the reference proton plan was used. The DMR algorithm therefore can play a big role in automated 














Dose mimicking has been presented previously and focussed on photon dose distributions only [14,15]. A 
voxel and DVH-based mimicking algorithm was introduced by XXXX to automatically improve a given 
reference photon dose [15]. The author evaluated the algorithm in a phantom study and found that the 
dose of the reference plan could further reduce the OARs dose while maintaining target coverage. 
McIntosh et al. applied a dose mimicking algorithm to a predicted dose distributions derived from dose 
distributions of a set of similar patients to automatically create a photon treatment plan for novel patients 
[14]. In this study we extended the dose mimicking algorithm from XXXX [15] toward photon to robust 
proton based dose mimicking. Also, the reducing OAR dose optimization part was extended to account for 
target robustness, taking multiple error scenarios into account. 
We acknowledge that the automated planning algorithm did not include automated beam angle selection. 
Therefore, we copied the beam configurations from the reference proton plan and automated beam angle 
selection will be subject of ongoing research. Moreover, to avoid inter-planner variability, all reference 
proton plans were created by one dosimetrist (XXXX). The reference photon plans were however 
extracted from the clinical database and generated by a variety of dosimetrists. This directly corresponds 
to the current clinical workflow for patient selection for proton therapy. 
Improving the target coverage has not been investigated in this study. It can sometimes be the case that 
photon plans have inadequate target coverage, especially if the target is close to the patient surface (due to 
the photon build-up effect), or due to proximity of dose-limiting critical structures (e.g. the optic 
structures). With a photon reference dose, the DMR algorithm currently does not seek to improve on it 
even though it may be possible with PBS and since the DMR algorithm in this study used DVH-
mimicking, any target underdosage in the photon plan will carry through into the proton plan, just not 
necessarily in the same region. In these (few) cases, the dosimetrist-optimised proton plan had the more 
clinically acceptable dose distributions. It is therefore important that the reference photon plans have 
sufficient target coverage to begin with. If target coverage of the photon plans was compromised, one 













study), or utilize some to also improve target coverage. Therefore, and also to study the full potential of 
the DMR algorithm, the DMR algorithm should be combined with e.g. a clinical goal-based normalization 
method for photon plans with underdosage. This was however outside the scope of the present study. 
Future research will focus on the application of dose mimicking for adaptive treatments. The goal is to 
achieve at least the same target DVHs of the original plan onto the repeat CT. Moreover, to further 
improve the photon dose, the ‘reducing’ function can be applied onto the photon dose distribution before 
patient treatment selection is performed. This would potentially reduce the NTCP values derived from the 
photon plan and consequently lead to a fairer selection of patients for proton therapy. 
In conclusion, the DMR algorithm automatically optimized a robust proton plan using a photon reference 
dose. We developed a fully automated tool to select head and neck cancer patients for proton therapy by 
combining the DMR algorithm with the model-based approach. 
 
Acknowledgements 





[1] Brada M, Pijls-Johannesma M, Ruysscher D De. Current clinical evidence for proton therapy. 
Cancer J 2009;15:319–24. doi:10.1097/PPO.0b013e3181b6127c [doi]. 
[2] XXXX 
[3] Lomax AJ, Böhringer T, Bolsi A, Coray D, Emert F, Goitein G, et al. Treatment planning and 
















[6] Cheng Q, Roelofs E, Ramaekers BLT, Eekers D, Van Soest J, Lustberg T, et al. Development and 
evaluation of an online three-level proton vs photon decision support prototype for head and neck 
cancer - Comparison of dose, toxicity and cost-effectiveness. Radiother Oncol 2016;118:281–5. 
doi:10.1016/j.radonc.2015.12.029. 
[7] Chanyavanich V, Das SK, Lee WR, Lo JY. Knowledge-based IMRT treatment planning for 
prostate cancer. Med Phys 2011;38:2515–22. doi:10.1118/1.3574874. 
[8] Appenzoller LM, Michalski JM, Thorstad WL, Mutic S, Moore KL. Predicting dose-volume 
histograms for organs-at-risk in IMRT planning. Med Phys 2012;39:7446–61. 
doi:10.1118/1.4761864. 
[9] Craft DL, Halabi TF, Shih H a., Bortfeld TR. Approximating convex Pareto surfaces in 
multiobjective radiotherapy planning. Med Phys 2006;33:3399. doi:10.1118/1.2335486. 
[10] Breedveld S, Storchi PRM, Keijzer M, Heemink AW, Heijmen BJM. A novel approach to multi-
criteria inverse planning for IMRT. Phys Med Biol 2007;52:6339–53. doi:10.1088/0031-
9155/52/20/016. 
[11] Thieke C, Küfer K-H, Monz M, Scherrer A, Alonso F, Oelfke U, et al. A new concept for 
interactive radiotherapy planning with multicriteria optimization: first clinical evaluation. 
Radiother Oncol 2007;85:292–8. doi:10.1016/j.radonc.2007.06.020. 
[12] Bokrantz R. Multicriteria optimization for volumetric-modulated arc therapy by decomposition 















[14] McIntosh C, Welch M, McNiven A, Jaffray DA, Purdie TG. Fully Automated Treatment Planning 
for Head and Neck Radiotherapy using a Voxel-Based Dose Prediction and Dose Mimicking 









Figure 1. Flow chart of the dose mimicking and reducing (DMR) algorithm embedded in the pipeline for 
∆NTCP assessment. Clinical information denotes the non-DVH predictors. The right panel shows the 
DMR algorithm in more detail as applied to proton automated treatment planning. DVH denotes dose 
volume histogram, ROI region of interest, and NTCP normal tissue complication probability. 
 
Figure 2. A transversal cross-section of a CT scan of a representative case with the nominal dose 
distribution of the clinical photon plan (left), the voxel-wise minimum dose of the robust dose mimicking 
and reducing (DMR) proton plan (middle), and the voxel-wise minimum dose of the dosimetrist-














Figure 3. Dose-volume histograms of the high (red) and low (green) dose clinical target volumes and the 
medial pharyngeal constrictor muscle (blue) and the contralateral parotid gland (orange). The legend 
indicates the plan type. The inlay shows the high dose target DVHs in more detail. The DVH-based 
mimicking of the target DVH is penalized within the grey surface, bounded by the photon reference DVH. 
 
Figure 4. (A) Bland-Altman plot of the difference of the ∑∆NTCP derived from the dose mimicking and 
reducing (DMR) plan and reference proton plan Pref. The green markers indicate agreement between the 
selected treatment modality (Y = protons; N = photons). The orange markers indicate conflicting 
decisions. (B) Normal tissue complication probability (NTCP) values of xerostomia, grade II-IV 
dysphagia, and tube feeding dependence (TFD) derived from the DMR plans and Pref plans. 
 
Figure 5. Bland-Altman plots of the relative volume receiving 95% of the prescribed dose (A) and the 
conformity index CIV95% (B) as derived from the voxel-wise minimum dose of the dose mimicking and 
reducing (DMR) plan and reference proton plan Pref. CTV1 and CTV2 denotes the clinical target volume 
of the high and low dose targets, respectively. The solid markers indicate the plans with a compromised 















Table 1. NTCP models and decision criteria 
NTCP model Organ(s) involved [all mean dose] 
Xerostomia (6 months; grade 2-3) Contralateral parotid  
Dysphagia (6 months; grade 2-3) Oral cavity; superior PCM 
Tube feeding dependence (6 months; grade 3-4) Contralateral parotid; superior PCM; inferior PCM; 
cricopharyngeal muscle. 
Decision criteria ∆NTCP   
∆NTCP of any ≤ grade 2 complication ≥ 10%   
∆NTCP of grade 3+ complication  ≥ 5%   
∑∆NTCP of < grade 2 complication ≥ 15 %   
Abbreviation: PCM = pharyngeal constrictor muscle. 
 
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
 
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
 
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
 
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
 
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
 
